Home > Insider Trading > Filing (0000899243-23-014751)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1088856	Corcept Therapeutics Inc	CORT	Pharmaceutical Preparations (2834)	770487658

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1817838	Douglas Joseph Lyon	C/O Corcept Therapeutics Incorporated 149 Commonwealth Drive Menlo Park CA 94025	Chief Accounting Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-06-06	10,000	$11.35	15,132	No	4	M	Direct
Common Stock	Disposition	2023-06-06	10,000	$23.60	5,132	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock option (right to buy)	Disposition	2023-06-06	10,000	$0.00	10,000	$11.35

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
56,571		2029-02-08	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were affected pursuant to Rule 144.
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $23.60 to $23.61. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
Includes 1,155 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023 and 1,411 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
Fully exercisable.